EL7.AI
Strategy BuilderCOT DataAdvanced NewsResearchNewEarnings CalendarEconomic Calendar
We use cookiesPrivacy Policy
EL7.AIEL7.AI

AI Financial Intelligence
Professional analysis of central bank decisions

© 2026 EL7.AI. All rights reserved.

Markets

  • News
  • Forex
  • Stocks
  • Crypto
  • Gold
  • Commodities
  • Indices
  • ETFs

Analysis

  • Fed
  • ECB
  • BLS
  • COT
  • Economic Calendar

Learn

  • Service Guide
  • Oil

Company

  • About
  • Contact
  • Data Methodology
  • AI Disclosure
  • Pricing
  • Enterprise
  • Terms
  • Privacy
  • Security
  • WhatsApp
Status data is currently unavailable

The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

Home
Stocks
Pebblebrook Hotel Trust
PEB

PEB Pebblebrook Hotel Trust

Pebblebrook Hotel Trust · NYSE
Market Closed
17.84
▼ ⁦-1.33%⁩ (-0.24)
Market Cap$2.0B
Beta1.41
52w Low52w High
9.9919.93
Last Week
⁦-1.92%⁩
Last Month
⁦+0.68%⁩
Last 3 Months
⁦+15.17%⁩
Last Year
⁦+68.14%⁩
EL7 Factor Analysis
How we score this
Overall22
Poor — bottom quartile of the marketTurnaroundF 4/9DistressBetter than 22% of Market stocks, per EL7's model
FactorScoreDistributionValueAvgRank
▸
Valuation
74
—17.8xTop tier
▸
Growth
18
2.1%▼7.1%Bottom tier
▸
Quality
18
1.2%▼4.5%Bottom tier
▸
Safety
34
6.4x▼2.6xBottom tier
▸
Capital Return
42
0.23%▼2.12%Around median
▸
Momentum
96
70.4%▲2.9%Top tier
▸
Sentiment
85
33Top tier
Fair Value
Current price$18
Analyst target · 5 analysts
$19
⁦+4%⁩
See it fairly priced
Range ⁦$12–$22⁩
vs
DCF (estimate)
$-0.81
⁦-105%⁩
Sees it clearly overvalued
⁦10.6⁩% discount · ⁦0⁩% growth
Bottom lineThe two methods disagree — estimate range ⁦$-0.81–$19⁩.

Estimates — analyst targets and a simplified DCF, not investment advice.

Compare in the screener
Premium content

Get Your Premium Account Now

  • Stock Deep Analysis
  • The Advanced News Platform
Recommended
Annual plan
$17/mo
Monthly plan
$29/mo

Analyst Consensus

This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.

Price Target· 5 analysts setting price target
$17.58
⁦-1.5%⁩
Current Price $17.84·Median $18.50
Low
$12.00
High
$22.00
Current price
$17.84
Average target
$17.58
Street summary

Price target review analysis for Pebblebrook Hotel Trust (PEB)

The consensus price target for PEB has seen a 6.96% increase over the past thirty days to reach $17.68; however, the stock is currently trading at $18.3, which exceeds this average. This upward adjustment reflects an improvement in expectations compared to the previous month, but it is met with caution as the current market price has already absorbed this rise and surpassed the average of estimates.

As of 2026-08-18
Revisions momentum · 30d
⁦-0.6%⁩
Average rating
★ 3.00
Hold
Analyst coverage
16
Buy conviction
25%
Target dispersion
56%
Wide
Analyst ratings over time16 analysts rating
1
3
9
1
2
Strong BuyBuyHoldSellStrong Sell
Rating trend — last 12 months3.06 → 3.00
Recent analyst moves
  • = Reiterate2026-08-11
    Cantor Fitzgerald
    Neutral
  • ⬆ Upgrade2026-07-31
    Compass Point
    Neutral
  • = Reiterate2026-07-22
    Citigroup
    Neutral
Premium content
Key Financials

Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.

StockSector medianSector averagetypical sector range
MetricValuePosition within sectorVerdict
  • P/E (TTM)
    —
    —
  • Forward P/E
    —
    —
  • EV / EBITDA
    13.84x
    3.68x29.40x
    Near median
  • FCF Yield
    7.8%
    -23.1%16.7%
    Strong
  • Revenue Growth YoY
    2.1%
    -14.0%37.7%
    Near median
  • EPS Growth YoY
    -25.9%
    -121.8%181.8%
    Near median
  • Gross Margin
    -5.0%
    -5.0%81.8%
    Weak
  • ROIC
    1.2%
    -4.2%9.5%
    Near median
  • Net Debt / EBITDA
    6.41x
    1.55x12.39x
    Low debt
  • Dividend Yield
    0.2%
    0.6%15.6%
    Low
  • Payout Ratio
    —
    —
  • Altman Z-Score
    0.35
    -0.883.10
    Near median
Financial Analysis
|

Stock Analysis

AI-generated
Based on 2026-07-30 data

Company Overview

Pebblebrook Hotel Trust owns a portfolio of upscale hotels and resorts in U.S. markets including San Francisco, Los Angeles, San Diego, Boston, and Washington, D.C., and generates revenue from rooms, food and beverages, banquets, and meetings. In Q2 fiscal 2026, resorts were the main growth driver, with RevPAR rising 12% and total RevPAR increasing 10.9%, while urban RevPAR grew 4.1% and total urban RevPAR growth was only 0.8%.

In Q2 fiscal 2026, the company reported revenue of $407.1 million, net income of $23.6 million, and earnings per share of $0.17. Same-property hotel EBITDA rose 7.1% to $123.3 million, and adjusted EBITDA reached $116.2 million, while adjusted FFO per diluted share was $0.68; these metrics exceeded the upper ends of management’s quarterly guidance for the second consecutive quarter.

Occupancy improved by approximately 130 basis points to 79.4%, average daily rate rose 4.7%, and RevPAR increased 6.5%, with pricing contributing approximately three-quarters of RevPAR growth. The company converted 4.8% growth in same-property total revenue into 7.1% hotel EBITDA growth, with expenses rising only 3.8% and the EBITDA margin expanding by 67 basis points to 30.6%. However, trailing 12-month data for 2026 show revenue of $1.5 billion and a net loss of $46.6 million, following an annual loss of $65.8 million in fiscal 2025.

What's Driving the Stock

  • Management raised its fiscal 2026 outlook to same-property RevPAR growth of between 4.5% and 5.5%, same-property EBITDA growth of between 8.2% and 10.5%, and adjusted FFO per diluted share of between $1.69 and $1.76.
  • Resorts led the improvement in Q2 fiscal 2026, generating approximately $16.5 million of the $18.3 million increase in portfolio revenue, while their EBITDA rose 18.5% with a 216-basis-point margin expansion; RevPAR also increased 20.3% in Newport and 22.8% at Estancia.
Earnings callEDGAR filings30-day newsInsider activity

Automated analysis for informational purposes only — not investment advice.

  • The San Francisco market achieved RevPAR growth of 16% and a 24.6% increase in hotel EBITDA, while EBITDA growth across the company’s seven hotels there during the first half of fiscal 2026 reached more than $13 million, or 110%, compared with the corresponding period.
  • Pricing strength supported the results, as transient customer revenue rose nearly 10% with a 7% increase in their average rates, while the average resort rate climbed by more than 12%; the company is also reducing discounts and promotions and its use of lower-priced wholesale channels.
  • Cost control helped convert revenue growth into faster earnings growth; room expenses increased 3.1% versus 6.6% growth in room revenue, and property insurance premiums renewed on June 1, 2026, declined by approximately 27%, or $6 million, compared with the previous year.
  • The company reduced its diluted share count by 4%, lifting adjusted FFO per share by 4.6% despite adjusted EBITDA declining by less than 1%. It also sold Chamberlain West Hollywood Hotel for $43.5 million and used $26.1 million to redeem $33.7 million of preferred shares at a 23% discount, generating an immediate increase in value of approximately $7.6 million.
  • Buying & Selling Case

    ▲ Buying Case4 pts

    • +Q2 fiscal 2026 demonstrated clear operating leverage, as same-property hotel EBITDA growth of 7.1% exceeded total revenue growth of 4.8%, and the margin expanded to 30.6%.
    • +Resorts and redeveloped properties provide a defined growth path; EBITDA increased by more than 40% at Paradise Point, approximately 26% in Newport, and 54.7% at Estancia, while management identified an additional $6 million of improvement opportunities in its latest redevelopment projects.
    • +The financial position improved during Q2 fiscal 2026, as net debt to trailing 12-month corporate EBITDA declined from 5.9 times at the end of fiscal 2025 to 5.3 times, while available liquidity totaled $1 billion.
    • +The sale of three hotels during the eight months ended July 30, 2026, for approximately $160 million at an aggregate EBITDA multiple of 15.4 times helped fund debt reduction and securities repurchases; adjusted FFO per share rose 23.8%, and free cash flow per share increased 69% to $0.76 during the first half of fiscal 2026.

    ▼ Selling Case6 pts

    • −Performance is uneven across markets; in Q2 fiscal 2026, RevPAR declined 9.1% in downtown San Diego and 9.9% in Washington, D.C., while urban hotel EBITDA fell 1% because of weak convention calendars, banquet and catering revenue, and government-related travel.
    • −The Q3 fiscal 2026 outlook indicates a clear slowdown from the 6.5% RevPAR growth recorded in Q2, as management expects growth of only between 1% and 3%, with adjusted EBITDA between $92.5 million and $96.5 million and adjusted FFO per share between $0.48 and $0.52.
    • −Debt remains relatively high despite the improvement, with net debt at 5.3 times trailing 12-month corporate EBITDA at the end of Q2 fiscal 2026, and the company still needs to fund $350 million of convertible notes due in 2026 using cash, expected cash flow, and its credit facility.
    • −The profitability of some hotels depends on improving the booking-channel mix; approximately 25% of the transient demand mix comes through online travel agencies, rising to the 20%–30% range at independent urban hotels, while discounts through some wholesale channels may reach 25%–30%.
    • −On July 30, 2026, management warned that shorter booking windows, the widening conflict in the Middle East, volatile trade policies, and a potential government shutdown could pressure the economy and travel; it therefore left its assumptions for the second half of fiscal 2026 unchanged despite the Q2 outperformance.
    • −Net income does not support a positive price-to-earnings ratio, as trailing 12-month data for 2026 showed a net loss of $46.6 million and negative earnings per share of approximately $0.37. The wide range of analyst price targets between $12 and $22, compared with a 52-week range between $9.99 and $19.93, also reflects substantial disagreement over the value of the operating recovery.

    Valuation

    The analyst consensus on PEB stock is Hold, with an average price target of $17.58 and a wide range between $12 and $22; the average is below the 52-week high of $19.93, while the highest target exceeds that high. No positive price-to-earnings ratio is available because of the $46.6 million net loss in the trailing 12-month data for 2026, making the valuation more dependent on the recovery in EBITDA and FFO and on asset values, while the divergence in analyst targets remains a risk factor.

    HoldAnalyst target: $17.58(-1.5%)

    Figures in the text are as of 2026-09-01; the live price is shown at the top of the page.

    FAQ

    What drove PEB’s Q2 fiscal 2026 results outperformance?

    Same-property hotel EBITDA reached $123.3 million, exceeding the upper end of management’s guidance by $6.6 million, while adjusted FFO per share was $0.68, or $0.06 above the upper end. RevPAR increased 6.5%, with approximately three-quarters of that growth coming from higher pricing as occupancy reached 79.4%. Resort growth and expense control also helped expand the EBITDA margin by 67 basis points to 30.6%.

    Why were Pebblebrook’s resorts the most important growth driver?

    Resort RevPAR rose 12% and total RevPAR increased 10.9% in Q2 fiscal 2026, lifting their EBITDA by 18.5%. Resorts generated approximately $16.5 million of the $18.3 million increase in portfolio revenue, with group revenue growing nearly 19% and food and beverage revenue increasing approximately 11%. Paradise Point stood out with EBITDA growth exceeding 40%, alongside RevPAR growth of 20.3% in Newport and 22.8% at Estancia.

    What is management’s outlook for the remainder of fiscal 2026?

    Management raised its fiscal 2026 same-property RevPAR growth outlook to a range of 4.5%–5.5% and expects same-property EBITDA growth of between 8.2% and 10.5%. It also raised the adjusted FFO per diluted share range to $1.69–$1.76. For Q3 fiscal 2026, however, it expects RevPAR growth of only between 1% and 3% because of shorter booking windows and economic, political, and geopolitical uncertainty.

    How is Pebblebrook using hotel sale proceeds and cash flow?

    The company sold three hotels during the eight months ended July 30, 2026, for approximately $160 million, at an aggregate EBITDA multiple of 15.4 times and an NOI capitalization rate of 4.6%. In Q2 fiscal 2026, it sold Chamberlain West Hollywood Hotel for $43.5 million, then used $26.1 million to redeem $33.7 million of preferred shares. During the first half of fiscal 2026, it repurchased 0.9 million common shares at an average price of $13.62 and redeemed 1.5 million preferred shares at an average discount of 23% to liquidation value.

    What are the main operating weaknesses monitored by PEB investors?

    In Q2 fiscal 2026, RevPAR declined 9.1% in downtown San Diego and 9.9% in Washington, D.C., while urban hotel EBITDA fell 1%. Portfolio-wide group revenue declined approximately 2%, and banquet and catering revenue at urban hotels fell nearly 20% because of weak convention calendars and a mix shift toward transient customers. Some independent urban hotels also rely on online travel agencies for between 20% and 30% of their transient demand mix, increasing the importance of improving booking channels and net rates.